TFRC and cancer: The transmembrane protein TfR is reported to be overexpressed up to 100-fold in cancer cells [22] and is strongly correlated with a malignant phenotype, both in PDAC [24] and HCC [23, 41], making these excellent therapeutic targets for an aptamer conjugate.